US Stock MarketDetailed Quotes

Lifecore Biomedical (LFCR)

Watchlist
  • 4.400
  • -0.150-3.30%
Close May 15 16:00 ET
  • 4.400
  • 0.0000.00%
Post 17:30 ET
165.04MMarket Cap-5.79P/E (TTM)

Lifecore Biomedical (LFCR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(Q3)Sep 30, 2025
(FY)May 25, 2025
(Q4)May 25, 2025
(Q2)Nov 24, 2024
(Q1)Aug 25, 2024
(FY)May 26, 2024
(Q4)May 26, 2024
(Q3)Feb 25, 2024
(Q2)Nov 26, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.7M
224.26%1.76M
-180.16%-206K
-38.65%5.35M
-576.71%-6.14M
92.64%-613K
101.47%257K
485.32%8.72M
87.91%-1.42M
154.74%1.29M
Net income from continuing operations
---14.98M
-163.91%-9.99M
-422.29%-38.72M
83.81%-1.15M
-146.22%-6.57M
-50.92%-16.23M
112.07%12.01M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
Operating gains losses
--3.16M
101.79%375K
118.66%7.37M
-50.73%1.18M
94.43%-1.15M
-350.00%-900K
-192.57%-39.48M
-90.04%2.4M
-201.74%-21M
-94,104.55%-20.68M
Depreciation and amortization
--2.31M
-1.25%1.98M
0.92%8.03M
-4.97%1.91M
15.74%2.04M
-8.07%1.99M
-39.64%7.95M
-24.57%2.01M
-37.57%2.01M
-39.93%1.77M
Deferred tax
----
----
----
----
372.50%109K
-231.58%-100K
-54.34%163K
----
----
-1,100.00%-40K
Other non cash items
--7.04M
21.14%6.37M
2.22%17.65M
-51.18%2.61M
38.19%5.03M
52.18%4.61M
1,515.53%17.27M
452.07%5.34M
34,940.00%5.26M
3,401.92%3.64M
Change In working capital
--5.48M
113.48%638K
-26.93%-4.7M
-123.09%-1.03M
-1,204.56%-8.73M
278.46%7.5M
-118.69%-3.7M
-38.34%4.44M
-739.46%-4.73M
-84.12%790K
-Change in receivables
--6.57M
105.05%65K
-116.22%-5.17M
-2,448.11%-2.49M
-39.49%-5.02M
152.26%6.02M
-122.10%-2.39M
-94.36%106K
63.67%-1.29M
-168.60%-3.6M
-Change in inventory
--930K
10.81%1.97M
791.88%7.69M
845.63%2.3M
895.08%2.43M
-95.88%-1.66M
105.82%862K
-958.33%-309K
133.69%1.78M
102.01%244K
-Change in prepaid assets
----
----
----
----
----
89.94%-244K
----
----
----
----
-Change in payables and accrued expense
---2.23M
65.29%-1.31M
-51.09%-7.59M
-165.00%-2.46M
-238.96%-4.1M
187.58%3.36M
-132.31%-5.02M
253.60%3.78M
-146.11%-3.76M
-110.12%-1.21M
-Change in other current assets
--209K
-130.77%-90K
-86.76%378K
85.52%1.61M
---925K
---214K
32.37%2.85M
--870K
---39K
----
-Change in other current liabilities
----
----
----
----
-343.09%-1.09M
145.61%1.15M
----
----
----
---246K
-Change in other working capital
----
----
----
----
-75.39%283K
-147.85%-1.46M
-102.95%-179K
----
----
1,697.22%1.15M
Cash from discontinued investing activities
Operating cash flow
--4.7M
224.26%1.76M
-180.16%-206K
-38.65%5.35M
-576.71%-6.14M
92.64%-613K
101.47%257K
485.32%8.72M
87.91%-1.42M
154.74%1.29M
Investing cash flow
Cash flow from continuing investing activities
-1.12M
72.72%-1.74M
65.13%-6.42M
22.71%-2.1M
42.74%-2.44M
32.29%-3.42M
-282.35%-18.4M
56.01%-2.71M
-217.23%-6.37M
-10.73%-4.26M
Net PPE purchase and sale
---1.12M
72.72%-1.74M
65.13%-6.42M
22.71%-2.1M
42.74%-2.44M
32.29%-3.42M
14.37%-18.4M
62.18%-2.71M
10.32%-6.37M
-10.73%-4.26M
Net business purchase and sale
----
----
----
----
----
----
--0
----
----
----
Net investment purchase and sale
----
----
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---1.12M
72.72%-1.74M
65.13%-6.42M
22.71%-2.1M
42.74%-2.44M
32.29%-3.42M
-282.35%-18.4M
56.01%-2.71M
-217.23%-6.37M
-10.73%-4.26M
Financing cash flow
Cash flow from continuing financing activities
-256K
-118.17%-1.39M
-14.45%6.42M
34.53%-402K
611.23%12.52M
-62.75%1.09M
-81.09%7.51M
-102.50%-614K
216.36%7.64M
-127.79%-2.45M
Net issuance payments of debt
--0
-108.28%-232K
-613.22%-14.79M
168.85%699K
-349.10%-10.94M
-25.45%1.68M
-7.63%2.88M
-99.04%260K
108.83%2.8M
-161.66%-2.44M
Net common stock issuance
----
--0
--23.85M
---8K
--23.84M
--1K
--0
--0
--0
----
Net preferred stock issuance
----
----
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
--0
-2,652.38%-1.16M
-735.53%-1.27M
79.02%-163K
-575.44%-385K
-181.35%-589K
---152K
83.89%-777K
---42K
---57K
Net other financing activities
---256K
----
-128.56%-1.37M
-858.76%-930K
----
-1,208.89%-589K
175.57%4.78M
95.93%-97K
----
----
Cash from discontinued financing activities
Financing cash flow
---256K
-118.17%-1.39M
-14.45%6.42M
34.53%-402K
611.23%12.52M
-62.75%1.09M
-81.09%7.51M
-102.50%-614K
216.36%7.64M
-127.79%-2.45M
Net cash flow
Beginning cash position
--17.47M
527.72%20.22M
-55.68%8.46M
76.28%5.42M
-36.13%5.52M
-55.68%8.46M
1,061.96%19.09M
4.17%3.07M
-52.84%3.22M
104.69%8.64M
Current changes in cash
--3.33M
-820.95%-1.36M
98.15%-197K
-47.15%2.85M
172.59%3.94M
71.84%-2.94M
-160.92%-10.63M
-66.61%5.39M
96.19%-148K
-307.86%-5.42M
End cash Position
--20.8M
513.60%18.86M
-2.33%8.27M
-2.33%8.27M
193.54%9.46M
-36.13%5.52M
-55.68%8.46M
-55.68%8.46M
4.17%3.07M
-52.84%3.22M
Free cash flow
--3.58M
100.32%25K
24.90%-13.62M
-45.86%3.25M
-188.60%-8.58M
69.85%-4.04M
53.40%-18.14M
163.62%6M
58.65%-7.79M
52.06%-2.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2026(Q3)Sep 30, 2025(FY)May 25, 2025(Q4)May 25, 2025(Q2)Nov 24, 2024(Q1)Aug 25, 2024(FY)May 26, 2024(Q4)May 26, 2024(Q3)Feb 25, 2024(Q2)Nov 26, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.7M224.26%1.76M-180.16%-206K-38.65%5.35M-576.71%-6.14M92.64%-613K101.47%257K485.32%8.72M87.91%-1.42M154.74%1.29M
Net income from continuing operations ---14.98M-163.91%-9.99M-422.29%-38.72M83.81%-1.15M-146.22%-6.57M-50.92%-16.23M112.07%12.01M81.97%-7.08M142.82%15.63M211.03%14.22M
Operating gains losses --3.16M101.79%375K118.66%7.37M-50.73%1.18M94.43%-1.15M-350.00%-900K-192.57%-39.48M-90.04%2.4M-201.74%-21M-94,104.55%-20.68M
Depreciation and amortization --2.31M-1.25%1.98M0.92%8.03M-4.97%1.91M15.74%2.04M-8.07%1.99M-39.64%7.95M-24.57%2.01M-37.57%2.01M-39.93%1.77M
Deferred tax ----------------372.50%109K-231.58%-100K-54.34%163K---------1,100.00%-40K
Other non cash items --7.04M21.14%6.37M2.22%17.65M-51.18%2.61M38.19%5.03M52.18%4.61M1,515.53%17.27M452.07%5.34M34,940.00%5.26M3,401.92%3.64M
Change In working capital --5.48M113.48%638K-26.93%-4.7M-123.09%-1.03M-1,204.56%-8.73M278.46%7.5M-118.69%-3.7M-38.34%4.44M-739.46%-4.73M-84.12%790K
-Change in receivables --6.57M105.05%65K-116.22%-5.17M-2,448.11%-2.49M-39.49%-5.02M152.26%6.02M-122.10%-2.39M-94.36%106K63.67%-1.29M-168.60%-3.6M
-Change in inventory --930K10.81%1.97M791.88%7.69M845.63%2.3M895.08%2.43M-95.88%-1.66M105.82%862K-958.33%-309K133.69%1.78M102.01%244K
-Change in prepaid assets --------------------89.94%-244K----------------
-Change in payables and accrued expense ---2.23M65.29%-1.31M-51.09%-7.59M-165.00%-2.46M-238.96%-4.1M187.58%3.36M-132.31%-5.02M253.60%3.78M-146.11%-3.76M-110.12%-1.21M
-Change in other current assets --209K-130.77%-90K-86.76%378K85.52%1.61M---925K---214K32.37%2.85M--870K---39K----
-Change in other current liabilities -----------------343.09%-1.09M145.61%1.15M---------------246K
-Change in other working capital -----------------75.39%283K-147.85%-1.46M-102.95%-179K--------1,697.22%1.15M
Cash from discontinued investing activities
Operating cash flow --4.7M224.26%1.76M-180.16%-206K-38.65%5.35M-576.71%-6.14M92.64%-613K101.47%257K485.32%8.72M87.91%-1.42M154.74%1.29M
Investing cash flow
Cash flow from continuing investing activities -1.12M72.72%-1.74M65.13%-6.42M22.71%-2.1M42.74%-2.44M32.29%-3.42M-282.35%-18.4M56.01%-2.71M-217.23%-6.37M-10.73%-4.26M
Net PPE purchase and sale ---1.12M72.72%-1.74M65.13%-6.42M22.71%-2.1M42.74%-2.44M32.29%-3.42M14.37%-18.4M62.18%-2.71M10.32%-6.37M-10.73%-4.26M
Net business purchase and sale --------------------------0------------
Net investment purchase and sale --------------------------0------------
Cash from discontinued investing activities
Investing cash flow ---1.12M72.72%-1.74M65.13%-6.42M22.71%-2.1M42.74%-2.44M32.29%-3.42M-282.35%-18.4M56.01%-2.71M-217.23%-6.37M-10.73%-4.26M
Financing cash flow
Cash flow from continuing financing activities -256K-118.17%-1.39M-14.45%6.42M34.53%-402K611.23%12.52M-62.75%1.09M-81.09%7.51M-102.50%-614K216.36%7.64M-127.79%-2.45M
Net issuance payments of debt --0-108.28%-232K-613.22%-14.79M168.85%699K-349.10%-10.94M-25.45%1.68M-7.63%2.88M-99.04%260K108.83%2.8M-161.66%-2.44M
Net common stock issuance ------0--23.85M---8K--23.84M--1K--0--0--0----
Net preferred stock issuance --------------------------0------------
Proceeds from stock option exercised by employees --0-2,652.38%-1.16M-735.53%-1.27M79.02%-163K-575.44%-385K-181.35%-589K---152K83.89%-777K---42K---57K
Net other financing activities ---256K-----128.56%-1.37M-858.76%-930K-----1,208.89%-589K175.57%4.78M95.93%-97K--------
Cash from discontinued financing activities
Financing cash flow ---256K-118.17%-1.39M-14.45%6.42M34.53%-402K611.23%12.52M-62.75%1.09M-81.09%7.51M-102.50%-614K216.36%7.64M-127.79%-2.45M
Net cash flow
Beginning cash position --17.47M527.72%20.22M-55.68%8.46M76.28%5.42M-36.13%5.52M-55.68%8.46M1,061.96%19.09M4.17%3.07M-52.84%3.22M104.69%8.64M
Current changes in cash --3.33M-820.95%-1.36M98.15%-197K-47.15%2.85M172.59%3.94M71.84%-2.94M-160.92%-10.63M-66.61%5.39M96.19%-148K-307.86%-5.42M
End cash Position --20.8M513.60%18.86M-2.33%8.27M-2.33%8.27M193.54%9.46M-36.13%5.52M-55.68%8.46M-55.68%8.46M4.17%3.07M-52.84%3.22M
Free cash flow --3.58M100.32%25K24.90%-13.62M-45.86%3.25M-188.60%-8.58M69.85%-4.04M53.40%-18.14M163.62%6M58.65%-7.79M52.06%-2.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More